These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 9642098)
1. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098 [TBL] [Abstract][Full Text] [Related]
2. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers. Xu L; Tsuji K; Mostowski H; Otsu M; Candotti F; Rosenberg AS J Virol Methods; 2004 Jun; 118(1):61-7. PubMed ID: 15158069 [TBL] [Abstract][Full Text] [Related]
3. Reliable generation of stable high titer producer cell lines for gene therapy. Rattmann I; Kleff V; Feldmann A; Ludwig C; Sorg UR; Opalka B; Moritz T; Flasshove M Intervirology; 2007; 50(3):197-203. PubMed ID: 17283445 [TBL] [Abstract][Full Text] [Related]
4. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols. Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568 [TBL] [Abstract][Full Text] [Related]
5. A comparative evaluation of gene transfer into blood cells using the same retroviral backbone for independent expression of the EGFP and deltaLNGFR marker genes. Giaretta I; Madeo D; Bonaguro R; Cappellari A; Rodeghiero F; Giorgio P Haematologica; 2000 Jul; 85(7):680-9. PubMed ID: 10897118 [TBL] [Abstract][Full Text] [Related]
6. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Schucht R; Coroadinha AS; Zanta-Boussif MA; Verhoeyen E; Carrondo MJ; Hauser H; Wirth D Mol Ther; 2006 Aug; 14(2):285-92. PubMed ID: 16697259 [TBL] [Abstract][Full Text] [Related]
7. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression. Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy. Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226 [TBL] [Abstract][Full Text] [Related]
9. A rapid screening procedure for the identification of high-titer retrovirus packaging clones. Murdoch B; Pereira DS; Wu X; Dick JE; Ellis J Gene Ther; 1997 Jul; 4(7):744-9. PubMed ID: 9282176 [TBL] [Abstract][Full Text] [Related]
10. Generation of high-titer retroviral vectors following receptor-mediated, adenovirus-augmented transfection. von Rüden T; Stingl L; Cotten M; Wagner E; Zatloukal K Biotechniques; 1995 Mar; 18(3):484-9. PubMed ID: 7779400 [TBL] [Abstract][Full Text] [Related]
12. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055 [TBL] [Abstract][Full Text] [Related]
13. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome. Hong Y; Yu SS; Kim JM; Lee K; Na YS; Whitley CB; Sugimoto Y; Kim S J Gene Med; 2003 Jan; 5(1):18-29. PubMed ID: 12516048 [TBL] [Abstract][Full Text] [Related]
14. A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors. Cockrell AS; Ma H; Fu K; McCown TJ; Kafri T Mol Ther; 2006 Aug; 14(2):276-84. PubMed ID: 16516556 [TBL] [Abstract][Full Text] [Related]
15. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cells. Staal FJ; Bakker AQ; Verkuijlen M; van Oort E; Spits H Cancer Gene Ther; 1996; 3(5):345-51. PubMed ID: 8894254 [TBL] [Abstract][Full Text] [Related]
16. The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange. Coroadinha AS; Schucht R; Gama-Norton L; Wirth D; Hauser H; Carrondo MJ J Biotechnol; 2006 Jul; 124(2):457-68. PubMed ID: 16529836 [TBL] [Abstract][Full Text] [Related]
17. Construction of new retroviral producer cells from adenoviral and retroviral vectors. Lin X Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327 [TBL] [Abstract][Full Text] [Related]
18. Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer. Sheridan PL; Bodner M; Lynn A; Phuong TK; DePolo NJ; de la Vega DJ; O'Dea J; Nguyen K; McCormack JE; Driver DA; Townsend K; Ibañez CE; Sajjadi NC; Greengard JS; Moore MD; Respess J; Chang SM; Dubensky TW; Jolly DJ; Sauter SL Mol Ther; 2000 Sep; 2(3):262-75. PubMed ID: 10985957 [TBL] [Abstract][Full Text] [Related]
19. A simple and reliable method for screening retroviral producer clones without selectable markers. Onodera M; Yachie A; Nelson DM; Welchlin H; Morgan RA; Blaese RM Hum Gene Ther; 1997 Jul; 8(10):1189-94. PubMed ID: 9215736 [TBL] [Abstract][Full Text] [Related]
20. A rapid procedure for screening fibroblast packaging cell lines for secretion of selectable retrovirus. Elefanty AG; Cory S Biotechniques; 1993 May; 14(5):770-4. PubMed ID: 8512701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]